Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07099222 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks
A Phase 1 study of Postoperative Pain and Constipation, sponsored by University of Arizona.
- Active
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07099222 is a Phase 1 study of Postoperative Pain and Constipation that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 100 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07099222, a Phase 1 study of Postoperative Pain and Constipation, is active but no longer recruiting, sponsored by University of Arizona.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to improve upon the standard practice of utilizing nerve blocks to enhance the satisfaction of patients undergoing shoulder, or foot and ankle surgery regarding their quality of pain control, the duration of their nerve blocks, as well as the avoidance of opioid medications and subsequently their undesirable side effects. The researchers hypothesize that dexmedetomidine and dexamethasone (Dex-Dex) will work synergistically as adjuncts in a low, non-weight based formula. This would allow the investigators to improve patient satisfaction by providing them with a superior means of pain control that is longer in duration with a decreased probability of unwanted side effects. The proposed clinical study will be a prospective, randomized control trial.
Conditions Studied
Interventions
- DRUG Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks
- DRUG Ropivacaine with low, non weight based Dexamethasone additive
Study Locations (1)
Arizona
- Banner - University Medical Center South - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07099222
The ClinicalTrials.gov registry entry for NCT07099222 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (57% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks is the first listed.
NCT07099222 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT07099222 about?
NCT07099222 is a clinical study titled "Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks". The goal of this clinical study is to improve upon the standard practice of utilizing nerve blocks to enhance the satisfaction of patients undergoing shoulder, or foot and ankle surgery regarding their quality of pain control, the duration of their nerve blocks, as well as the avoidance of opioid me...
What is the current status of trial NCT07099222?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2024-10-10. Estimated completion is 2026-12-31.
What conditions does trial NCT07099222 study?
This clinical trial studies the following conditions: Postoperative Pain, Constipation, Dizziness, Nausea and Vomiting, Postoperative, Pain After Surgery.
What interventions are being tested in trial NCT07099222?
The interventions under investigation include: Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks (DRUG), Ropivacaine with low, non weight based Dexamethasone additive (DRUG).
Who is sponsoring clinical trial NCT07099222?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07099222 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers
COMPLETED · Phase 1
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Characterization of Acute Pain
RECRUITING
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.